NCT04581343 2025-05-04PanCAN-SR1Pancreatic Cancer Action NetworkPhase 1 Completed10 enrolled 26 charts
NCT02900664 2022-03-29A Study of PDR001 in Combination With CJM112, EGF816, IlarisĀ® (Canakinumab) or MekinistĀ® (Trametinib)NovartisPhase 1 Completed283 enrolled
NCT02334748 2020-05-19A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 StudiesNovartisPhase 3 Completed31 enrolled 7 charts
NCT02911857 2018-08-20An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever SyndromesNovartisPhase 3 Completed4 enrolled 7 charts